Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vyne Therapeutics Inc (NQ: VYNE )

2.660 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.660
Bid (Size) 2.050 (10)
Ask (Size) 3.050 (5)
Prev. Close 2.660
Today's Range 2.660 - 2.660
52wk Range 1.670 - 6.789
Shares Outstanding 51,511,845
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VYNE Stock Earnings: VYNE Therapeutics Beats EPS, Misses Revenue for Q1 2024
VYNE stock results show that VYNE Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
+16.67%
+16.67%
1 Month
+13.19%
+13.19%
3 Month
+22.58%
+22.58%
6 Month
-31.79%
-31.79%
1 Year
-44.20%
-44.20%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Recap: VYNE Therapeutics Q4 Earnings
Via Benzinga
Top 4 Health Care Stocks That May Rocket Higher In Q1
Via Benzinga
Recap: VYNE Therapeutics Q3 Earnings
Via Benzinga
Recap: VYNE Therapeutics Q1 Earnings
Via Benzinga
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
Via Benzinga
Topics Stocks
Exposures US Equities
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Positive Momentum For VYNE Therapeutics' Psoriasis, Rheumatoid Arthritis Candidate - Analyst Expresses Encouragement
Via Benzinga
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Vyne Therapeutics Stock Is Climbing
Via Benzinga
Nasdaq Gains Over 1%; McDonald's Reports Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
VYNE Therapeutics (NASDAQ: VYNE) Shares Positive Preclinical Data for VYN201 as a Potential Treatment for Idiopathic Pulmonary Fibrosis
Via Spotlight Growth
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.